Risk factors for mortality among kidney transplant recipients with COVID-19 in Saudi Arabia: a case-control study
Abstract Background The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has profoundly impacted global health, leading to over 74 million confirmed cases and 1.67 million deaths by December 2020. In Saudi Arabia, extensive measures were implemented to mitigate the spread of the virus....
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-10994-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850156622052065280 |
|---|---|
| author | Dema A. Alissa Rawan Almasuood Baraa Alghalyini Hala Tamim Mohammed Alaa Raslan Abdul Rehman Zia Zaidi Bader Abou Shaar Mhd Malek Al Masri Adnan Abdul Karim Wejdan Aburas Waled Aburas Ahmed H. Al-jedai Reem S. Almaghrabi |
| author_facet | Dema A. Alissa Rawan Almasuood Baraa Alghalyini Hala Tamim Mohammed Alaa Raslan Abdul Rehman Zia Zaidi Bader Abou Shaar Mhd Malek Al Masri Adnan Abdul Karim Wejdan Aburas Waled Aburas Ahmed H. Al-jedai Reem S. Almaghrabi |
| author_sort | Dema A. Alissa |
| collection | DOAJ |
| description | Abstract Background The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has profoundly impacted global health, leading to over 74 million confirmed cases and 1.67 million deaths by December 2020. In Saudi Arabia, extensive measures were implemented to mitigate the spread of the virus. Kidney transplant recipients, due to their immunosuppressed status, are particularly vulnerable to severe COVID-19 outcomes. This study aims to identify risk factors associated with mortality in COVID-19-infected kidney transplant patients in Saudi Arabia. The primary objective is to identify mortality risk factors among COVID-19-infected kidney transplant patients. The secondary objective is to compare clinical management and outcomes between deceased and recovered patients. Methodology This case-control study matched 82 deceased kidney transplant patients (cases) with 151 survivors (controls). Data were collected from the National Registry for COVID-19 Mortality and King Faisal Specialist Hospital and Research Centre (KFSH&RC) for patients diagnosed between March 2020 and January 2021. Key variables included demographic information, comorbidities, clinical symptoms, and treatment details. Statistical analyses involved chi-square tests and multivariable logistic regression to assess associations with mortality. Results Among cases, 93.9% required ICU admission, and 95.1% were intubated. Males constituted 73.2% of cases, with 53.7% aged over 60. Cardiovascular comorbidities were more prevalent among cases (97% vs. 87.4%, p = 0.01). and presented more frequently with fever, cough, and respiratory distress. In multivariable analysis, fever, shortness of breath, and desaturation were associated with increased mortality odds. Notably, patients who discontinued immunosuppressive therapy had higher mortality odds (OR = 63.2, p = 0.083), whereas those who held or adjusted their therapy had significantly lower odds (OR = 0.1, p = 0.042; OR = 0.0, p = 0.007). Bacterial infections also increased mortality risk (OR = 56.6, p = 0.009). Conclusion This study identifies critical risk factors for mortality among kidney transplant patients infected with COVID-19 in Saudi Arabia. The findings underscore the need for tailored clinical management strategies to improve outcomes in this vulnerable population. Further research is warranted to explore long-term implications and effective treatment protocols. |
| format | Article |
| id | doaj-art-43bb46fcc0214c5fa59d443f210472f9 |
| institution | OA Journals |
| issn | 1471-2334 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Infectious Diseases |
| spelling | doaj-art-43bb46fcc0214c5fa59d443f210472f92025-08-20T02:24:26ZengBMCBMC Infectious Diseases1471-23342025-04-012511710.1186/s12879-025-10994-4Risk factors for mortality among kidney transplant recipients with COVID-19 in Saudi Arabia: a case-control studyDema A. Alissa0Rawan Almasuood1Baraa Alghalyini2Hala Tamim3Mohammed Alaa Raslan4Abdul Rehman Zia Zaidi5Bader Abou Shaar6Mhd Malek Al Masri7Adnan Abdul Karim8Wejdan Aburas9Waled Aburas10Ahmed H. Al-jedai11Reem S. Almaghrabi12Therapeutic Affairs Deputyship, Ministry of HealthTherapeutic Affairs Deputyship, Ministry of HealthDepartment of Family and Community Medicine, College of Medicine, Alfaisal UniversityDepartment of Family and Community Medicine, College of Medicine, Alfaisal UniversityColleges of Medicine and Pharmacy, Al-Faisal UniversityDepartment of Family and Community Medicine, College of Medicine, Alfaisal UniversityDepartment of Family and Community Medicine, College of Medicine, Alfaisal UniversityColleges of Medicine and Pharmacy, Al-Faisal UniversityColleges of Medicine and Pharmacy, Al-Faisal UniversityTherapeutic Affairs Deputyship, Ministry of HealthCollege of Pharmacy, University of HailTherapeutic Affairs Deputyship, Ministry of HealthOrgan Transplant Centre of Excellence, King Faisal Specialist Hospital and Research CenterAbstract Background The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has profoundly impacted global health, leading to over 74 million confirmed cases and 1.67 million deaths by December 2020. In Saudi Arabia, extensive measures were implemented to mitigate the spread of the virus. Kidney transplant recipients, due to their immunosuppressed status, are particularly vulnerable to severe COVID-19 outcomes. This study aims to identify risk factors associated with mortality in COVID-19-infected kidney transplant patients in Saudi Arabia. The primary objective is to identify mortality risk factors among COVID-19-infected kidney transplant patients. The secondary objective is to compare clinical management and outcomes between deceased and recovered patients. Methodology This case-control study matched 82 deceased kidney transplant patients (cases) with 151 survivors (controls). Data were collected from the National Registry for COVID-19 Mortality and King Faisal Specialist Hospital and Research Centre (KFSH&RC) for patients diagnosed between March 2020 and January 2021. Key variables included demographic information, comorbidities, clinical symptoms, and treatment details. Statistical analyses involved chi-square tests and multivariable logistic regression to assess associations with mortality. Results Among cases, 93.9% required ICU admission, and 95.1% were intubated. Males constituted 73.2% of cases, with 53.7% aged over 60. Cardiovascular comorbidities were more prevalent among cases (97% vs. 87.4%, p = 0.01). and presented more frequently with fever, cough, and respiratory distress. In multivariable analysis, fever, shortness of breath, and desaturation were associated with increased mortality odds. Notably, patients who discontinued immunosuppressive therapy had higher mortality odds (OR = 63.2, p = 0.083), whereas those who held or adjusted their therapy had significantly lower odds (OR = 0.1, p = 0.042; OR = 0.0, p = 0.007). Bacterial infections also increased mortality risk (OR = 56.6, p = 0.009). Conclusion This study identifies critical risk factors for mortality among kidney transplant patients infected with COVID-19 in Saudi Arabia. The findings underscore the need for tailored clinical management strategies to improve outcomes in this vulnerable population. Further research is warranted to explore long-term implications and effective treatment protocols.https://doi.org/10.1186/s12879-025-10994-4COVID-19MortalityKidney transplant recipientsSaudi ArabiaRisk factors |
| spellingShingle | Dema A. Alissa Rawan Almasuood Baraa Alghalyini Hala Tamim Mohammed Alaa Raslan Abdul Rehman Zia Zaidi Bader Abou Shaar Mhd Malek Al Masri Adnan Abdul Karim Wejdan Aburas Waled Aburas Ahmed H. Al-jedai Reem S. Almaghrabi Risk factors for mortality among kidney transplant recipients with COVID-19 in Saudi Arabia: a case-control study BMC Infectious Diseases COVID-19 Mortality Kidney transplant recipients Saudi Arabia Risk factors |
| title | Risk factors for mortality among kidney transplant recipients with COVID-19 in Saudi Arabia: a case-control study |
| title_full | Risk factors for mortality among kidney transplant recipients with COVID-19 in Saudi Arabia: a case-control study |
| title_fullStr | Risk factors for mortality among kidney transplant recipients with COVID-19 in Saudi Arabia: a case-control study |
| title_full_unstemmed | Risk factors for mortality among kidney transplant recipients with COVID-19 in Saudi Arabia: a case-control study |
| title_short | Risk factors for mortality among kidney transplant recipients with COVID-19 in Saudi Arabia: a case-control study |
| title_sort | risk factors for mortality among kidney transplant recipients with covid 19 in saudi arabia a case control study |
| topic | COVID-19 Mortality Kidney transplant recipients Saudi Arabia Risk factors |
| url | https://doi.org/10.1186/s12879-025-10994-4 |
| work_keys_str_mv | AT demaaalissa riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT rawanalmasuood riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT baraaalghalyini riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT halatamim riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT mohammedalaaraslan riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT abdulrehmanziazaidi riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT baderaboushaar riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT mhdmalekalmasri riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT adnanabdulkarim riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT wejdanaburas riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT waledaburas riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT ahmedhaljedai riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy AT reemsalmaghrabi riskfactorsformortalityamongkidneytransplantrecipientswithcovid19insaudiarabiaacasecontrolstudy |